Magenta Therapeutics, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Magenta Therapeutics, Inc. (MGTA) is 29.25

According to Magenta Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 29.25. This represents a change of 60.20% compared to the average of 18.26 of the last 4 quarters.

Magenta Therapeutics, Inc. (MGTA) Historical Current Ratio (quarterly & annually)

How has MGTA Current Ratio performed in the past?

The mean historical Current Ratio of Magenta Therapeutics, Inc. over the last ten years is 12.00. The current 29.25 Current Ratio has changed 24.28% with respect to the historical average. Over the past ten years (40 quarters), MGTA's Current Ratio was at its highest in in the June 2024 quarter at 36.46. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Magenta Therapeutics, Inc. (MGTA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Magenta Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Magenta Therapeutics, Inc. (MGTA) Average Current Ratio

How has MGTA Current Ratio performed in the past?

The current Current Ratio of Magenta Therapeutics, Inc. (MGTA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Magenta Therapeutics, Inc. (MGTA) Current Ratio vs. Peers

How is MGTA’s Current Ratio compared to its peers?

Magenta Therapeutics, Inc.’s Current Ratio is greater than Pluristem Therapeutics Inc. (0.33), greater than Rein Therapeutics Inc. (0.40), greater than Lunai Bioworks Inc. (0.19), greater than GreenLight Biosciences Holdings (2.01), greater than Satsuma Pharmaceuticals, Inc. (6.75), greater than Eyenovia, Inc. (1.97), greater than bluebird bio, Inc. (0.55), greater than Lumos Pharma, Inc. (5.69), greater than AlloVir, Inc. (12.14), greater than Spyre Therapeutics, Inc. (8.97),

Build a custom stock screener for Magenta Therapeutics, Inc. (MGTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Magenta Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Magenta Therapeutics, Inc. (MGTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Magenta Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.